Trump announces deals with Eli Lilly, Novo Nordisk to slash weight loss drug prices, offer some Medicare coverage
The deal cuts monthly costs of GLP-1 obesity drugs to as low as $149 and expands Medicare and Medicaid coverage to about 10% of Medicare enrollees, officials said.
- President Trump announced deals with Eli Lilly and Novo Nordisk to cut prices of obesity drugs for Medicare and Medicaid beneficiaries in 2026.
- The deals will offer obesity treatments directly to consumers at discounted prices on a website called TrumpRx.gov starting in January.
- Certain Medicare patients will pay $50 per month for approved GLP-1 drugs, and upcoming obesity pills from Lilly and Novo Nordisk will cost $145 per month initially.
284 Articles
284 Articles
MAHA skeptical of Trump plan to curb obesity with cheap Ozempic
Advocates of the Make America Healthy Again agenda have expressed skepticism over President Donald Trump’s agreement with pharmaceutical companies to lower prices and expand access to blockbuster anti-obesity and diabetes medications. Following Trump’s Oval Office announcement Thursday about drastically lowering costs for Ozempic and other GLP-1 drugs, MAHA leaders told the Washington Examiner that they would prefer to see an elevation of holis…
7 burning questions about Trump’s big deal for cheaper weight loss drugs
WASHINGTON — The Trump administration’s deal to expand access to and lower the cost of weight loss drugs has left industry leaders, public health experts, and patients with a host of open questions. The administration’s agreements with Eli Lilly and Novo Nordisk center on their GLP-1 offerings, which officials said would now be available to more Americans — at prices that would ultimately save the government money. But the details of the deal — …
President Trump Announces Significant Pharmaceutical Deal to Lower Drug Prices, and Answer Media Questions
President Trump made an announcement today in the oval office highlighting two Rx companies, Eli Lilly and Company and Novo Nordisk, to dramatically reduce the prices Americans pay for some of the world’s most popular drugs. [Fact Sheet Here] Following the drug company announcement President Trump took questions from the media. The press Q&A is […] The post President Trump Announces Significant Pharmaceutical Deal to Lower Drug Prices, and Answ…
TrumpRx: Trump Scores Significantly Lower Prices For Popular Weight Loss Drugs - Real News Now
President Donald Trump announced a sweeping deal on Thursday to slash prices for some of the country’s most sought-after weight loss and diabetes medications, marking a major win for Americans struggling with high out-of-pocket drug costs. Under the new agreements, pharmaceutical giants Eli Lilly and Novo Nordisk will dramatically reduce prices on GLP-1 drugs, including Zepbound, Wegovy, and Ozempic. These medications, widely used for weight los…
Coverage Details
Bias Distribution
- 58% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium



































